Skip to main content
. 2004 Aug 16;143(2):257–268. doi: 10.1038/sj.bjp.0705927

Figure 4.

Figure 4

(a) Western blot of phospho-CREB in BAL neutrophils of LPS-treated rats 30 min after 1 mM DbcAMP addition in the presence of PKA inhibitors (14–22=1 μM protein kinase A inhibitor 14–22 amide myristoylated, H-89=1 μM). (b) Western blot of phospho-CREB in BAL neutrophils of LPS-treated rats 30 min after 10 μM forskolin addition in the presence of PDE4 inhibitors (rolipram=0.1–10 μM, Ariflo=0.1–10 μM).